glp 1 2025 How Employers Can Manage GLP-1 Costs in Their Health Plans GLP-1 RA prescription trends: January
Description
Maximum XOS production was observed at 40 C and pH 5.4 with 2% xylan (10 mL) and 4.4 U/mL enzyme (1 mL)
Cons Compounded formulations are not the same as FDA-approved brand products, and long-term trial data are limited
Difference between groups was analysed by one-way ANOVA followed by the post-hoc Tukey-Kramer test
When a medication is not stored as directed, it may not perform as expected, and patients may not get the full benefit of their treatment plan
